Zheng J, Xie Y, Ren L, Qi L, Wu L, Pan X et al (2021) GLP-1 improves the supportive ability of astrocytes to neurons by promoting aerobic glycolysis in Alzheimers disease
Certain formulations have separate FDA approvals for chronic weight management (Wegovy, Saxenda, Zepbound), with higher-dose semaglutide and tirzepatide capable of producing 1015% weight reduction, while other GLP-1 agents typically yield more modest weight loss
Supplementing with reduced glutathione can help maintain optimal health and wellbeing
While your digestion handles fats differently now, the mechanism of tirzepatide does not rely on the gallbladder to work effectively
Available from: Isaacs J, Gonalves J, Strohal R, Castaeda-Hernndez G, Azevedo V, Drner T, et al
It works by affecting appetite, fullness, stomach emptying and blood sugar regulation